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ABSTRACT 
DISSECTION OF MACROPHAGE ACTIVATION USING T CELL 
HYBRIDOMA DERIVED LYMPHOKINES 
William Stewart Futch, M.S. 
Medical College of Virginia-Virginia Commonwealth University, 1985  
Major Director: Lawrence B.  Schook, Ph.D. 
Macrophage phenotype/function can be modulated by various T-<!ell 
lymphokines (LK). The alteration of macrophage phenotype is a result of 
LK concentration, duration of exposure, and the level of macrophage 
activation when obtained from in vivo sources through elicitation by 
either sterile irritants or immune cellular mechanisms. In order to dissect 
macrophage activation into discrete signals T cell hybridomas were 
constructed by fusing HAT sensitive BW5147 cells with nylon-wool 
purified, con A stimulated T cells. The resulting T cell hybrids were 
screened for their ability to: (a) protect macrophages from the 
cytopathic effect of Naegleria; (b) induce class II MHC gene product (Ia 
antigen) expression; (c) increase cytostasis and tumoricidal activity; and 
(d) alter ectoenzyme profiles on either resident or thioglycollate (TG) 
elicited macrophages. Two hybridomas (T-3 and T-9) were selected for 
further evaluation because of their activity patterns. Supernatants from 
T-3 and T-9 were compared with cloned Y -interferon (y -IFN) for 
alteration of biological activities. Both T-3 and T-9 were able to protect 
resident macrophage cells from Naegleria but had no protective effect on 
TG-macrophages. T-9 supernatant had patterns of activity similar to Y­
IFN while T-3 patterns were different. The addition of anti-Y-IFN 
removed T-9 cytostatic activity while not affecting T-3 induced activity. 
The LK inducing protection from the cytopathic effect of Naegleria 
x 
lysate is not Y-IFN but another molecular moiety. It was also shown that 
Y -IFN does not protect T G-macrophages from the destructive effects of 
adenylate cyclase produced by Bordetella pertussis. We conclude that 
activation of macrophages for the destruction of tumor cells and 
activation for protection against amoeba and bacteria occur via different 
biological pathways. Furthermore, we have proposed an association 
between the cell cycle and the responsiveness of resident and TG-elicited 
macrophages to specific LK. 
xi 
INTRODUCTION 
When Metchnikoff first introduced the term "macrophage" in 1883 the 
major function of these cells was considered to be the rapid phagocytosis of 
foreign particles. Now over a century later, the role of the mononuclear 
phagocyte in host defense has been found to be far more complex, playing an 
important role in resistance to attack by parasites, tumors, and microorganisms 
(31,47,52, 75). 
The major e mphasis of this work is directed toward macrophage effector 
functions against microbial infection and neoplastic cells. While the activation 
of macrophage for these two mechanisms occurs through similar stages, the 
inducing signals appear to be different (31,21 ,1 1 3,114). Furthermore, 
macrophage populations appear to exhibit variable degrees of efficiency in 
performing these functions (1 13). 
The macrophage has also been implicated in a variety of other functions 
both immunological and nonimmunological. Their secretory function has been 
well documented (91). The macrophage is also of considerable importance 
because of its role in the regulation of the immune response (97,98,1 26) and may 
also play a role in vascularization and wound healing (97,113). 
The diversity of macrophage function has lead to attempts to describe 
discrete stages of activation, generally defined by the degree of microbicidal or 
tumoricidal activity. These stages have been characterized as resident, 
inflam matory (responsive, primed), or activated. Normal, unstimulated 
peritoneal macrophages, are considered resident macrophages. Macrophages 
elicited by i.p. injection of a sterile agent such as thioglycollate, casein, or 
protease-peptone are inflammatory macrophages. These inflammatory 
macrophages are functionally "responsive" to LK(s). After LK treatment these 
cells are prepared to become tumoricidal or microbicidal and are considered 
2 
primed. Exposure of these primed macrophages to a second signal such as 
endotoxin or LK produces a fully activated macrophage. Injection of Calmette­
Guerin bacillus (BeG) or £. parvum (f. acnes) also results in the elicitation of 
peritoneal macrophage which have tumoricidal activity. 
Mononuclear phagocytes are an extremely heterogeneous population of 
cells. They differ according to a number of biochemical and histochemical 
parameters and also differ markedly according to their tissue distribution (lungs, 
liver, bone, spleen, connective tissue, serous cavities) (29,97). Even within one 
location, macrophages vary in their morphology, state of differentiation, and 
functional parameters (97,113). 
There have been many attempts to explain the functional heterogeneity of 
the macrophage. paems (29) has suggested that while inflammatory 
macrophages originate from bone-marrow-derived blood monocytes, the resident 
macrophage is a self-renewing population. This hypothesis is based upon 
observations that resident macrophages regularly enter mitosis and give rise to 
progeny of their own kind. Van Furth (29) believes that all macrophages 
originate from bone-marrow and that inflam matory stimuli and lymphocyte 
derived biological modifiers, lymphokines (LK), have a direct effect on the 
macrophage and induce functional heterogeneity in a homogenous population of 
bone marrow precursor cells. Bursuker and Goldmann (13) have proposed that a 
heterogeneous population of bone marrow-derived macrophage-precursor cells 
exists and that subsets of these precursors are differentially expanded under 
normal and inflammatory conditions. A heterogeneous population of monocytes 
then enters the circulation and under the influence of LK they migrate into local 
tissues. It is at this level where the tissue macrophage interacts with local 
factors which determine the final functional state. A similar proposal suggests 
that functional heterogeneity arises at the level of the monocyte and that 
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monocyte·s give rise to separate lineages of macrophages which eventually result 
in true macrophage populations that reside in specific tissues or organs (112). 
Both of these models result in terminally differentiated subpopulations in which 
transition from one subpopulation to another would be severely restricted and 
require retrodifferentiation to the level of a common precursor (112). 
Sorg and Newmann (1 12) have proposed a model in which macrophages pass 
sequentially through a series of intermediate, stable phenotypes. Under this 
mechanism terminally differentiated macrophages can rearrange their genetic 
program and switch to phenotypes that can reenter into the cell cycle. While it 
is not clear which of these models is correct, the use of biochemical markers to 
define distinct stages of macrophage differentiation and purified LK as tools for 
regulating macrophage homeostasis, should allow for the manipulation of 
macrophage effector functions and study of its regulation. 
Origins of Mononuclear Phagocytes 
The mononuclear phagocytes are of bone marrow (BM) origin arising from a 
pluripotential stem cell common to all hematopoietic cells (29). As this stem 
cell becomes committed, it gives rise to the monoblast. The murine monoblast 
has a cell cycle time of 12  hours and divides to give rise to two promonocytes 
(29). The resulting promonocytes have a cell cycle of 16 hours. These cells give 
rise to the monocytes which leave the BM into the peripheral blood after 24  
hours and d o  not normally undergo any further cell division (29). After 
approximately 48 hr mature monocytes will randomly emigrate from the blood 
into various tissues and serous cavities and become macrophages (29,97,134). 
Monoblasts are difficult to identify by current techniques; however, 
Nichols et a1. (82) reported that they contain no granules and others report that 
they lack any functional activity usually as sociated with monocytes (123). The 
promonocyte is a large cell, (10-15 \lm in length) with a large 
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nuclear/cytoplasmic ratio, and prominent nucleoli. The azurophil granules are 
i mmature and are peroxidase positive as are the cisternae of the rough 
endoplasmic reticulum (RER) and the Golgi complex (83). It also contains the 
lysozomal enzymes arylsulfatase and acid phosphatase (82). In the bone marrow 
monocyte, the RER and the Golgi complex are peroxidase negative and there is 
the appearance of a second peroxidase negative granule. No arylsulfatase 
reactivity is present and acid phosphatase activity is greatly reduced. The 
nucleus is large with a horseshoe shape and the nuclear/cytoplasmic ratio is 
decreased in comparison to the promonocyte (83). The mature blood monocyte 
continues to form peroxidase negative granules and exhibit cellular membrane 
ruffling (83). 
Distinct morphological and biochemical changes accompany the 
development of monoblasts into mature monocytes (6). These changes are 
associated with the acquisition of functional character. As promonocytes 
develop into blood monocytes and ultimately into tissue macrophages there is a 
progressive increase in the number of receptors for the Fc portion of 
immunoglobulins and the C3b components of complement (6,134). There is also 
an increased capacity for pinocytosis and phagocytosis (6) and an increasing 
number of the cells become esterase positive. The development of these five 
markers occurs in the majority of bone marrow derived mononuclear phagocytes 
and are the basis by which they are identified (6). In addition to these general 
features of the mononuclear phagocytes, there are many biochemical properties 
and functions acquired in response to inflammation that distinguish the resident 
tissue macrophage from the inflam matory macrophage. 
Normally, as mononuclear phagocytes leave the BM they are fairly well 
developed, express high levels of Ia antigen, and functionally responsive to 
lymphokine. As they m igrate into the tissues they appear to become down-
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regulated or suppressed (l05). It is possible that in the absence of activating 
stimuli, the macrophage autoregulates its own suppression. Resident 
macrophages, which are functionally at rest, produce sUbstantial amounts of 
prostaglandin E (predominantly PGE2) which inhibits macrophage proliferation 
and clonal expansion (6). It is particularly interesting that when promonocytes or 
monocytes are removed from the bone marrow (BM) and cultured in vitro, they 
develop phenotypic and functional characteristics which resemble resident tissue 
macrophages (6). 
Receptors and Surface Antigens 
Macrophages are known to bear over 30 distinct receptors (5). Changes in 
the receptors being expressed can be used to characterize their state of 
differentia tion. 
As previously mentioned, the macrophage expresses receptors involved 
with phagocytosis: i.e. the Fc receptors, receptors for complement, and a 
receptor for mannose/fructose/N-acetylglucosamine terminated glycoproteins 
(56,97). Peritoneal macrophages express two major Fc receptors. FcRI 
recognizes Y 2a while FcRII recognizes the y1 and Y2b IgG isotypes (5,127). 
The binding of these receptors reportedly results in the enhance ment of 
phospholipase A2, the arachidonic acid cascade and increased intracellular levels 
of cyclic AMP (5). The number of FcRI and FcRII copies has been shown to vary 
according to the maturational stage and this variation can be induced by 
exposure to t3 or Y -interferon (130). The number of FcRI and FcRII receptors 
are higher in inflammatory than in resident peritoneal macrophages (5). 
Immunologically mediated inflammation (BCG-elicited macrophage) yields 
macrophages with increased FcRI but decreased FcRII receptors (5, 27). 
Macrophages in all stages of differentiation have been shown to express 
receptors for complement components. The two major receptors, CR1 and CR3, 
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recognize and bind different portions of the third component of complement (C3) 
(5). It appears that C R1 and CR3 are functionally altered during development. 
Resident macrophages bind but can not ingest complement�oated RBC's, while 
inflammatory macrophages will bind and phagocytize antigen by these receptors 
(5). Griffin (34) has shown that in resident macrophages complement receptors 
are not freely mobile in the phospholipid bilayer of the plasma membrane and 
therefore do not gather around a bound particle to permit endocytosis. In 
inflammatory macrophages this is not the case as complement receptors are 
fully mobile (5,34). 
Peritoneal macrophages also have receptors for glycoproteins ending in 
mannose, fucose, or N-ecetylglucosamine residues (45,1 1 8). This receptor 
probably aids in the recognition and phagocytosis of bacteria and other 
microorganisms. As is the case with complement receptors, macrophage 
activation leads to a decrease in the number of these receptors (27). 
Expression of class II major histocompatibility antigens (la antigens) are 
important in antigen presentation by macrophage to lymphocytes. Rosenthal 
and Shevach (98) first noted that the macrophage and T cells must be 
histocompatible in order to cooperate together in the immune response. Only Ia 
positive macrophages can function as accessory cells for the presentation of 
antigen and removal of these cells eliminates the immune response (139). The 
presence of Ia antigens is characteristic of the activated macrophage. Resident 
and inflam matory macrophages show low levels of Ia antigen; however, immune 
elicited macrophages contain a large percentage of Ia�ositive cells (1 25,1 26). 
The expression of Ia is induced in vitro by lymphokines (MAP or Y-IFN), while it 
is down regulated by prostaglandin E2(PGE2) (5). 
Recently, Ham ilton et al. (37) has correlated the expression of receptors 
for the iron-binding glycoprotein, transferrin with macrophage differentiation. 
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Inflammatory macrophages and monocytes express large numbers of receptors 
for this molecule, while resident macrophages and immune-t!licited macrophages 
express significantly fewer receptors (37). Interestingly, the transferrin receptor 
is down regulated by the addition of macrophage activating factor (MAF) or 
recombinant y-IFN (37) and is therefore a useful marker for examining the 
mechanis m of action of these LKls on macrophages. 
Many investigators have associated the expression of membrane 
ectoenzymes with macrophage development, the most well characterized of 
which is the 51nucleotidase (51N). This enzyme hydrolyzes the phospho ester 
linkage in 5 1-mononucleotides, liberating a nucleotide and inorganic phosphate 
(23). Resident peritoneal cells have been shown to contain high levels of this 
enzyme. In contrast, macrophages elicited by sterile or immune inflammatory 
reagents exhibit dramatically reduced levels (22). This decrease has been shown 
to result from increased membrane recycling and decreased synthesis of the 
enzyme (5). Because of the inverse relationship between expression of 5'N and 
the inducibility of Ia antigen by M AF, this activity is thought to be regulated by 
a signal(s) which leads to increased responsiveness to MAF (5) or perhaps 
macrophages with low 51N express receptors for y -IFN. 
The ectoenzymes, alkaline phosphodiesterase I (APD-I) and leucine amino­
peptidase (LAP), have also been used to phenotypically characterize macrophage 
populations. APD-I functions to sequentially re move terminal monophosphate 
nucleotides from the 51 end of polyribonucleotides or oligodeoxyribonucleotides 
starting at a nucleotide with a free 31-OH group at the tail of the chain (24). 
Leucine aminopeptidase sequentially cleaves amino acids from the N-terminal 
end of peptides in a nonspecific manner (71). Both of these enzymes have been 
found to increase several fold in inflammatory macrophages as compared to 
resident macrophages. In activated macrophage, LAP levels remain high; 
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however, the level of APD-I appears to be even lower than that seen in resident 
macrophages (22). 
Peritoneal macrophages express receptors for regulatory molecules which 
may act to induce or suppress macrophage functions. Many of these receptors 
are constitutively expressed and are not altered as the macrophage proceeds 
through the various stages of activation. The receptor for acetylated proteins 
and lipoproteins are of this type. The triggering of this receptor stimUlates 
secretions of neutral proteases and in primed macrophages results in secretion 
of plasminogen activator and cytolytic proteinase (5). The receptors for Cl 2  
macroglobulin are also present throughout the development o f  tumoricidal and 
microbicidal functions. Binding of this receptor inhibits neutral protease 
secretion and therefore acts in conjunction with the receptor for acetylated 
proteins and lipoproteins to autoregulate the secretion of plasminogen activator 
and cytolytic proteinase (5). 
The receptor for colony-stimulating factor (eSF) is expressed early on in 
development and all macrophage populations respond to it, although the 
magnitude of proliferation may vary. Inflammatory macrophages show the 
greatest proliferation in response to esp, while resident and activated 
macrophages are much less responsive (5). In addition to cellular proliferation, 
engagement of this receptor results in increased spreading in mature 
macrophages and differentiation of pre-monocytes and monocytes into 
macrophages (130). 
Many receptors for LK are expressed only as a result of humoral signals 
received earlier in differentiation. Identifying these receptors has proven 
difficult until recently due to the lack of purified factors. The migration 
inhibitory factor (MIF) receptor has been identified as a L-fucose containing 
glycoprotein (41). Receptors for macrophage activating factor (MAP) have been 
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much more difficult to define because this molecule has been identified 
functionally in Con A stimulated lymphocyte supernatants. It is now thought 
that activity once attributed to this one factor may indeed be do to several 
lymphokines (30,31). Gamma interferon is believed to be one form of M AP (5) 
and receptors appear to be present in inflammatory (TG�licited) macrophages 
but lacking in resident macrophages (37). The binding of Y -IFN to its receptor 
leads to increased cytolytic activity (89,95). 
Peritoneal macrophages express many other receptors too numerous to 
mention in detail. Some of these include receptors for lactoferrin, chemotactic 
factors, fibronectin, high density lipoproteins, fibrinogen, and insulin (5,97). 
Secretory Functions 
If any one characteristic could possibly begin to explain the diverse 
functions of the macrophage perhaps it is the secretory function. The 
macrophage is able to manufacture, secrete, and/or store a vast array of 
biologically active products, which include hydrolytic enzymes, cell stimulatory 
proteins and a vast array of other molecules. On exposure to a variety of 
inflammatory-inducing substances the macrophage is triggered to release a 
variety of acid hydrolases (cathepsins, hyaluronidase, B �lucuronidase, acid 
phosphatase, aryl sulfatase) (5). These preformed enzymes are released within 4-
6 hours from lysozomes (97) and release has been shown to be specific for 
potentially pathogenic substances since the phagocytosis of biologically 
unreactive substances does not induce their release (91). Although their exact 
extracellular function is not known these enzymes are believed to participate in 
the initiation and perturbation of tissue destruction seen in chronic inflammatory 
diseases (91,97). 
Another major secretory product of the macrophage is lysozyme, a 14,000 
molecular weight protein which hydrolyzes N-acetylmuramic-6 -1,4-N-acetyl-
10 
glucosamine linkages of peptidoglycans in bacterial cell walls (5,91,97). Unlike 
the acid hydrolases, lysozyme is a constituitive product of the macrophage 
(91,97) and is secreted in large quantities by all macrophage populations (5). 
A third group of hydrolytic enzymes produced by the macrophage are the 
neutral proteases. This group includes the enzymes elastase, collagenase, 
plasminogen activator, and a cytolytic proteinase (91,97). Unlike the acid 
hydrolases, these enzymes are synthesized following a stimulatory event and 
their production can be blocked by protein synthesis inhibitors (91,97). 
While resident macrophages secrete low levels of neutral proteases, 
inflam matory macrophages secrete SUbstantial amounts. Werb and Gordon (13 3) 
have reported that TG-elicited macrophages secrete high levels of collagenase 
while resident macrophages produce barely detectable amounts. Resident 
macrophages however, can be triggered to secrete slightly higher levels by 
phagocytic stimuli. These findings appear to be true for elastase, plasminogen 
activator, and cytolytic proteinase enzymes as well (5,91,97). 
The macrophage also secretes a variety of reactive oxygen intermediates. 
These include superoxide anion, hydrogen peroxide, and hydroxyl radical 
(5,6,50,78,97). Evidence suggests that these oxygen metabolites play a role in the 
tumoricidal and microbicidal functions of the macrophage . Murray et al. (75) 
has shown that these highly reactive molecules are involved in killing of the 
intracellular parasite Toxoplasma gondii. Others have demonstrated that the 
release of H202 by activated macrophages leads to the rapid lysis of certain 
tumor cell targets (78,79,80,81). Inflammatory macrophages have been shown to 
have a 1 0-fold greater secretory capacity of reactive oxygen intermediates 
than resident macrophages (100). However, macrophages immunologically 
activated !!! vivo by BGG or f. acnes secrete the largest amounts of these 
oxygen intermediates (6). 
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Macrophages serve as a major source of arachidonic acid metabolites such 
as prostaglandins of the E series, leukotriene C4 and B4, and thromboxane B2 
(5,92,97,107). Prostaglandin E1, is known to greatly enhance collagenase 
production in stimulated macrophages. They have also been shown to exhibit 
antiproliferative and immunosuppressive effects (5,97) on T cells and to inhibit 
generation of many lymphokines (68). Thromboxane B2 is a principle metabolite 
of the macrophage as a result of phagocytic stimuli (92) and is a potent mediator 
of vasoconstriction and platelet aggregation (36). Two major leukotrienes are 
also secreted. Leukotriene C4 (slow-reacting substance of anaphylaxis) and 
leukotriene B4, a potent chemotactic factor are generated by the lipooxygenase 
pathway (97). 
Macrophages produces a variety of compounds with stimulatory activity on 
cells involved in immune regulation. Macrophages produce CSF similar to that 
produced by the fibroblast L929. This factor is produced by all macrophages and 
acts to regulate macrophage morphology, differentiation, and proliferation (5). 
Macrophages also secrete Class I (�) interferon. Secretion of � -IFN has 
been shown to be induced by CSF (130). It has been suggested that this enables 
the macrophage to auto regulate its function by providing the signals necessary 
for differentiation into a responsive macrophage (130). Warren and Vogel (130) 
have recently shown � -IFN can increase Fc-mediated phagocytosis in the 
presence of highly purified, � -IFN depleted CSF. This increased activity is 
eliminated with the addition of anti-6 -IFN. Furthermore, �-IFN can provide the 
appropriate signal necessary for activation for tumoricidal activity although it is 
quantitatively less effective than Y-IFN (90). 
Interleukin 1 (1L-1) or lymphocyte activating factor is a major signal for 
lymphocyte stimUlation. It is released by macrophages in response to viral, 
bacterial, and fungal infection (5). IL-1 appears to be identical to endogenous 
12 
pyrogen which induces the febrile response and regulates several phenomena 
associated with inflam m ation (97,1 10). 
Activated and inflam matory macrophages secrete components of both the 
classical and alternative complement pathways. These include Clq, C2, C3, C4, 
C5, factor B, factor D, properdin, C3b-inactivator, and BIH (5,11,62). 
Supernatants from antigen stimulated lymphocytes have been shown to enhance 
production of these complement components (62). Resident and inflammatory 
macrophages secrete the largest quantities and produce the largest number of 
individual products compared to activated macrophages (5). Scott et al. (107) 
have shown that the overall secretory capacity of these products is down 
regulated as a consequence of the activated state. 
Macrophage Regulatory and Effector Functions 
Macrophages exhibit three major functional roles in the immune response. 
First, they act as scavengers of extracellular debris (5,97,134). Second, they 
play a regulatory role in the induction of the immune response, having been 
shown to display both activational and suppressive controls (5,97,1 25). Third, 
macrophages serve as effector cells capable of destroying viruses (5), bacterial 
(50), intracellular and extracellular parasites (12,50,86), and tumor cells 
(2,4,5,6,80). 
The phagocytic role of the macrophage has long since been established 
(15,134). Although earlier investigators had demonstrated the phagocytic 
capability of the macrophage (15), Metchnikoff was the first to establish their 
importance and demonstrated that animals resistant to certain bacterial 
infections had an increased capacity for phagocytosis of m icroorganisms (5,15). 
Virtually all macrophage populations in various stages of differentiation 
express some phagocytic ability (97). Cells from the promonocyte stage onward 
have been demonstrated to phagocytose latex beads nonspecifically and IgG 
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coated particles specifically by Fc receptors (5,97,1 30).  Opsonized particles 
coated with the C3 component of complement can also be ingested via a 
complement receptor (25,34). 
Phagocytosis can be divided into three stages: attachment to the 
macrophage, ingestion of the particle, and digestion within a phagolysosome 
(15,134). The initial attachment and recognition occurs by the receptors 
previously mentioned. Normally, complement and IgG coated particles are 
phagocytized by a zipper-like mechanism in which F c and C3 receptors on the 
surface of the macrophage direct movement of the membrane over the surface 
of the particle (134). However, particle attachment does not always indicate 
phagocytic recognition (93). At low receptor densities particles may bind 
macrophage surface receptors without being ingested (93,134). If receptors on 
the macrophage surface are not mobile enought in the fluid phase of the 
membrane to allow zippering then phagocytosis is also interrupted at binding 
(5,134). 
When zippering is triggered, the particle is surrounded by the macrophage 
membrane. Once this circumferential zippering is completed, an endocytic 
vacuole known as a phagosome is formed. This phagosome fuses with a primary 
or secondary lysosome to form a phagolysosome (134). Within this compartment, 
the phagocytosed material is digested at low pH by a barrage of hydrolytic 
enzymes (134). 
Phagocytosis is greatly enhanced in inflammatory macrophages as 
compared to resident peritoneal macrophages (5,1 1 2). This increased efficiency 
is partly due to an increase in the number of FcRI and FcRII in inflammatory 
macrophages (5). In contrast, resident macrophages have higher numbers of 
complement receptors but because they are not freely mobile in the membrane, 
bound particles are not ingested (5,34). Inflammatory macrophages also have 
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increased reserves of phosphocreatine which is a major energy source during 
phagocytosis (5). 
The positive immunogenic role of the macrophage is a result of two well 
defined s teps. First, they have been shown to remove extracellular debris 
(antigen); and second, they can retain degraded pep tides (antigen) in lymphoid 
tissue for presentation to immunospecific lymphocytes. Mosier (73) first 
demonstrated the requirement for adherent cells in the immune response to 
sheep red blood cells (SRBC). He cultured murine spleen cells in plastic dishes 
for 30 m in and removed the adherent cells. Neither fraction (adherent or 
nonadherent cells) could respond in vitro to SRBC. However, when the fractions 
were mixed together anti-SRBC antibodies were produced. Nossal et al. (87) 
were the first to show that in vivo, injected antigen localizes in the lymph node 
medulla and persists for long periods of time within the macrophages. 
A third step, which until recently was somewhat obscure, is the actual 
presentation of antigen to the lymphocytes. In order for an accessory cell to 
perform this function, it must be able to express Class II glycoproteins (Ia 
antigens) on its surface, process antigen, and synthesize and release interleukin 1 
(126). 
The importance of Ia antigens was first described by Rosenthal and 
Shevach (109) who demonstrated that macrophages and T cell must be 
histocompatible in order to result in lymphocytic proliferation. Using strain 2 
and strain 13 guinea pigs, they found that antigen-pulsed macrophages could 
activate syngeneic lymphocytes while allogeneic macrophages failed to activate 
T cell proliferation. Because the M HC's of strain 2 and strain 13 guinea pigs 
differ only at the I-region, they proposed that identity between I-region antigens 
is required for effective T-cell-macrophage interactions. In an accompanying 
paper, (109) they showed that antigenic non-responders were a result of a 
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macrophage defect in which antigen could not be presented to T lymphocytes in 
an effective way. 
Further studies have shown that it is the macrophage and not the T cell Ia 
antigens that are important in these interactions. Thomas and Shevach (120) 
demonstrated that the receptor on the helper T cell recognizes antigen in 
association with the H-21 region product and this product does not need to be 
expressed by both the macrophage and the T cell. In addition, the killing of Ia­
positive macrophage with anti-Ia and complement was shown to impair the 
immune response to antigen (139) while removal of Ia-positive T cells had no 
effect (12 1). 
Macrophages have been demonstrated to internalize antigenic proteins 
where they are catabolized to smaller fragments and later found either 
associated with the cell surface or released into the culture supernatant (1 26). 
Using lysosomotropic agents, such as chloroquine or ammonium chloride, to raise 
the pH of lysosomes results in the inhibition of antigen-presenting functions. 
This indicates the need for antigen to be internalized and processed in an acidic 
vesicle before it can be expressed on the cell surface for presentation (126). 
Unanue (126) has shown that untreated macrophages can present hen egg 
lysozyme (HEL) to T cell hybridoms, paraformaldehyde-fixed cells could not. 
However, trypsin treated HEL could be presented by live macrophages or 
prefixed macrophages. Amino acid analysis of the immunogenic peptide revealed 
a very nonpolar portion and an area of predominantly polar amino acids. 
It has been suggested that globular proteins or proteins of microbial origin 
must go through a processing stage in order to be expressed on the macrophage 
surface membrane. The fragment expressed must contain an immunogenic 
determinant, distinct from those of self-proteins, in association with a nonpolar 
stretch of amino acids for anchorage in the membrane (126). These immunogenic 
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fragments then either complex directly with Ia molecules or are located in close 
proximity with Ia due to random collisions in the membrane (126). 
When a T helper cell precursor recognizes antigen in association with Ia 
antigens, the macrophage is stimulated to secrete IL-l. IL-1 in turn, serves as a 
stimulus for T cell activation which signals T helper cell precursors to 
differentiate into helper effector cells. These cells express receptors for and 
secrete IL-2 (T cell growth factor) (42). 
Several investigators have demonstrated the need for 1L-1 for efficient 
antigen presentation. Kramer and Unanue (58) indicated that while B cells are 
1 0-100  times less effective at presenting KLH, the addition of macrophage 
conditioned media was able to increase their accessory function. Scala and 
Oppenheim (101) showed that monocytes pulsed with antigen and treated with 
paraformaldehyde could only present antigen to T lymphocytes in the presence of 
IL-l. Monocytes fixed prior to the antigen pulse could not present antigen even 
when IL-1 was added to the culture. 
Thus the macrophage appears to be perfectly suited for its accessory role 
in antigen presentation. It is capable of interacting with a variety of antigenic 
proteins, processing them for expression on the cell membrane in association 
with Ia antigens, and secretes IL-l. While the role of other Ia positive cells in 
antigen presentation is unclear, the macrophage appears to be of major 
importance. 
In addition to its immunostimulatory role, the macrophage also plays a 
vital role in suppression of the immune response. Macrophages !!! vitro have 
been shown to inhibit lymphocyte functions, particularly at high numbers or if 
activated for tumoricidal or microbicidal functions (125). It is this suppressive 
role of the activated macrophage that may prevent immune responses from 
becoming exceedingly destructive (97). 
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The suppressive effects of the macrophage are best realized by the 
secretion of prostaglandins, thymidine, oxygen intermediated and other factors 
(97,125). Prostaglandins have been shown in vivo to decrease antibody formation 
and in vitro to lower antigen and mitogen induced lymphocyte stimulation (97). 
Cyclooxygenase inhibitors such as indomethacin have been shown to reverse the 
inhibitory effects of macrophages in macrophage -lymphocyte interactions (1 25); 
however, it reportedly has no effect on macrophage tumoricidal activity (11 1). 
Thymidine appears to be a potent inhibitor of the immune response by interfering 
with the conversion of cytidylate to deoxycytidylate and blocking DNA synthesis 
(116). High levels of thymidine have been shown to inhibit the proliferation of 
rapidly dividing lymphocytes and thymocytes (117). 
Macrophages have· also been found to secrete large quantities of the 
enzyme arginase which catabolize the essential amino acid arginine and 
reportedly suppresses lymphocyte proliferation (18,59,97). Oxygen metabolites, 
particularly hydrogen peroxide may also inhibit lymphocyte proliferation in 
response to antigen (69). Given that the addition of reducing agents such as 2-
mercaptoethanol enhances the proliferative response of lymphocytes to antigen 
(125), a proposed immunosuppressive role for oxygen intermediates is not 
unfounded. 
The term "activated" in reference to large, nonspecifically microbicidal 
macrophages was first introduced by Mackaness (63). Later, when the 
tumoricidal activity of these macrophages was realized (40) the definition was 
expanded. 
Development of the activated macrophage appears to be a complex, 
multistep process. As monocytes leave the circulation and enter into the tissues, 
the macrophage becomes exposed to a variety of positive and negative effector 
molecules that induce morphological, metabolic, and physiological changes 
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activating them for a variety of functions (5). It should be strongly emphasized 
that macrophage 
synonymous with 
(30,31,51,52,135). 
activation for destruction of tumor cells is not always 
activation for the destruction of microorganisms 
Because this term has been operationally defined, 
investigators should take care to indicate the function for which the 
macrophage has been activated. 
It is now well established that the macrophage plays a central role in 
protection against facultative and obligate bacterial pathogens (51,63,108). 
Activated macrophages are also important in the elimination of viruses and 
extracellular parasites and protozoans (30,56,85,136). 
Metchnikoff first noted that macrophages from immune animals showed 
increased resistance to bacterial challenge due to their increased phagocytosis 
and microbicidal activity (5). It was later determined that macrophages 
responding to infection with one organism could nonspecifically resist infection 
against antigenically unrelated bacteria (9). Fowles et al. (28) demonstrated the 
link between specific cell-mediated immunity and the nonspeCific functions of 
the activated macrophage when they demonstrated that culture supernatants 
from antigen specific T lymphocytes could activate macrophages for nonspecific 
protective functions. 
The mechanism by which macrophages recognize such a wide range of 
microorganisms is not well known; however, the ability to distinguish and respond 
to unrelated microorganisms has been demonstrated to occur by several 
mechanisms. Multicellular parasites (e.g. Schistosoma, Trichinella) are killed 
extracellularly by an IgE-dependent mechanism (26,20). Capron et al. (14) 
demonstrated that serum IgE acted on the macrophage because preincubation of 
schistosomula with immune serum did not induce killing while treated 
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macrophages were activated within one hour. 
Fc-mediated phagocytosis is probably the primary immune-mediated mechanism 
for microbial attachment to macrophages. The protozon parasite Toxoplasma 
gondii is bound to the macrophage plasma membrane via the FcU receptors when 
opsonized with serum IgG (74). Phagocytosis directed by these receptors is 
particularly important with encapsulated bacteria such as Steptococcus 
pneumoniae, Hemophilus influenzae, and Neisseria meningitidis (74). 
Comple ment receptors (CRl, CR3) also play a role in the uptake of 
microorganisms and is believed to play an important role when a nonimmune host 
is first confronted with an organism. Lipopolysaccharide from bacterial cell 
walls has been shown to bind complement thereby promoting the uptake of the 
organism (74). Nonimmune receptors may also play a role in the binding and 
uptake of some microbes. These receptors have been suggested to play an 
important role in the defense against microorganisms which fail to stimulate a 
strong humoral response and in nonimmune animals (74). Receptors recognizing 
glycoproteins ending in mannose or frucose have been reported to play a role in 
the phagocytosis of Salmonella typhimurium, Klebsiella aerogenes, and 
Corynebacterium parvum (132). 
Attempts to demonstrate activation of macrophages for microbicidal 
activity in vitro were initially futile due to the extracellular replication of 
target microbes (77). The replacement of facultative intracellular bacteria by 
obligate intracellular parasites avoids this problem and allows an accurate 
assessment of the role macrophage 
microorganisms. 
in protection against pathogenic 
In nonimmune macrophages, Toxoplasma, Leishmania, and Trypanosoma 
�. enter by endocytosis but then reside in different locations within the cell. 
The uptake of these protozoans fails to trigger an oxidative respiratory burst or 
20 
synthesis of lysosomal enzymes. Toxoplasma gondii has been demonstrated to 
prevent fusion of the phagosome with lysosomes by altering the phagosomal 
membrane by an unknown mechanism. Leshmania amastigotes replicate within 
the phagolysosome by inactivating lysosomal enzymes and Trypanosoma cruzi 
lyse the phagosomal membrane and replicate in the cytosol (52). 
When exposed to antigen and ConA"",timulated splenic supernatants, 
microbicidal activity can be induced in both resident and inflammatory 
macrophages (52,85). This acquisition of microbicidal activity against 
Leshmania, Toxoplasma, Trypanosomes, and Candida has been demonstrated to 
be closely linked with increased production of H202 and other reactive oxygen 
intermediates (52,74,75,76,85). 
Murray et al. (75) has reported the augmented oxidative capacity of I. 
gondii activated macrophages to be antigen speCific since boosting T. gondii 
immune mice (i.p.) with the same organism resulted in increased H202 and 
superoxide anion (02-) generation. Boosting with BCG or PPD (purified protein 
derivative) did not increase these oxygen intermediates. These differences are 
thought to result from increased lymphokine production in antigen"",timulated T 
cells (76). 
Microbicidal activity may possibly be enhanced by other nonoxidative 
mechanisms; however, their importance here remains to be established. Some of 
these mechanisms include lowering the pH of the phagosomes, secretion of 
lysozymal hydrolases, and the production of cationic proteins and peptides (5,60). 
The macrophage has also been found to play an important role in the 
destruction of neoplastic cells. Alexander and Evans (7) first reported that 
exposure of peritoneal macrophage to LPS or double standard RNA rendered 
them cytotoxic to both syngeneic and allogeneic lymphoma cells. Hibbs et al. 
(38,39) found that macrophages activated for microbicidal functions using agents 
such as BCG, .£. parvum, !!. pertussis, and I. gondii were also cytotoxic to 
2 1  
tumor cells but not to normal untransformed cells. Consequently, because these 
macrophages were obtained from mice responding to microbial infections, 
tumoricidal macrophages were considered to be "activated" by definition. 
Macrophage-mediated tumor cell cytotoxicity is a multistep process which 
involves: specific binding of neoplastic target cells; prolonged contact with the 
tumor cell target; and secretion of lytic products which appear to alter the 
integrity of the target membrane (5). Resident and thioglycollate-elicited 
macrophages have been shown to interact very little with adherent or 
nonadherent tumor cell targets in vitro. In contrast, macrophages activated by 
macrophage activating factor (M AF) and LPS have been shown to come into 
intimate contact with tumor cell targets (5,6). Using electron microscopy, 
activated macrophages can be observed to spread out over their target in 
clusters with their cytoplasmic membranes closely molded to it for several hours 
(6). After 6 hr of contact with activated macrophages, tumor cell division is 
almost completely abrogated (6). This cytostatic activity is followed by swelling 
of the cytoplasmic membrane (6) and complete lysis of the neoplastic cell within 
1 6-18 hours (4). 
The activated macrophage appears to be highly efficient and selective in 
destruction of neoplastic cells in vitro. One macrophage appears capable of 
lysing several targets; and when added to mixed cultures of neoplastic and 
nonneoplastic cells, they are not cytolytic for the normal cells (6). 
Specific binding of tumor cell targets can be augmented by the treatment 
of inflam matory, but not resident, macrophages with LK (6,65). Binding capacity 
appears to be maximal after 8-12 hours of LK treatment (48). Augmented binding 
requires metabolically active macrophages; however, dead targets are bound (6). 
Intact microtubules and microfilaments are also necessary as demonstrated by 
the inhibition of tumor cell binding by the colchicine treatment (48). Specific 
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binding has also been shown to require the presenae of a trypsin sensitive 
membrane structure and the presence of divalent aations (6). Examination of 
tumor cell binding by macrophages using electron microscopy reveals a small 
space or cleft between the points of contact. It has been proposed that this 
space functions to concentrate and protect lytic mediators (5,6,48). 
While the activated macrophage has been reported to secrete many factors 
cytotoxic to other cells (4), few have been well characterized. The most 
extensively studied of these factors involved with macrophage-mediated tumor 
aytolysis includes arginase, hydrogen peroxide, and a novel cytolytic protease. 
Neoplastic cells have been demonstrated to require large amounts of 
arginine and because macrophages are known to secrete high concentrations of 
arginase it has been considered a possible mediator of macrophage-mediated 
tumor cytotoxicity. The major support for arginase in this role is the finding 
that arginine can block tumor cytolysis when included in macrophage 
cytotoxicity assays (4). Arginase probably does not play a major role because it 
is seareted by inflam m atory as well as aativated macrophages and therefore does 
not correlate with tumor cell cytotoxicity (4,5,6). 
Hydrogen peroxide has been implicated in microbicidal function of the 
macrophage and may also play a role in tumoricidal aativities. It has been 
reported to lyse a variety of tumor cells; however, the effective concentration 
varies widely (79,80). Inhibition of H202 activity by catalase and anaerobiosis do 
not inhibit macrophage-mediated cytolysis. Therefore, while H202 may play a 
role in tumor destruction, apparently it is not a sufficient mediator on its own. 
Adams et al. (1)  first reported the presence of a novel serine protease 
present in the supernatants of BCG-activated macrophages but not in the 
supernatants from resident and inflammatory macrophages. This cytolytic 
protease (CP) is quite potent, having a 50% cytolytic concentration of around 1.0 
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x lO-9 M (4). Much evidence has accumulated indicating the importance of CP in 
macrophage-mediated lysis of neoplastic cells. First, there is a strong 
correlation between the secretion of CP and the development and expression of 
tumoricidal activity. Resident and inflammatory macrophages do not display 
tumoricidal activity nor do they secrete CPo Immune-elicited (BCG, �. �) 
or inflam matory macrophage treated with LK and LPS in vitro are cytolytic and 
secrete CP spontaneously (4,48). Second, low molecular weight protease 
inhibitors block CP activity and inhibit tumoricidal activity of activated 
macrophage and do so by acting at the target injury stage (47). Third, binding of 
viable tumor cells or plasma membranes by BCG-elicited macrophage results in 
secretion of CP while normal cells do not trigger CP release (4). Furthermore, 
addition of tumor cells to inflammatory macrophage does not stimulate CP 
release (48). Finally, the kinetics for the destruction of neoplastic cells in vitro 
with CP is similar to that of macrophage-mediated tumor cell cytotoxicity (4,6). 
Taken together, these findings indicate that CP is a major effector of 
macrophage-mediated tumor cytotoxicity. 
Adams et al. (2) have shown that while H2 02 is unable to mediate tumor 
cytolysis, it appears to act synergistically with CPo Exposure of tumor cells to 
non-lytic concentrations of H202 (lO-6M or less) along with non-lytic 
concentrations of CP results in target cell lysis. It is possible that other 
secretory products of activated macrophages may act in conjunction with each 
other in a similar manner to mediate tumor cell killing. 
Another lytic m echanism for the destruction of tumor cells by activated 
macrophages involves antibody-dependent cellular cytotoxicity (ADCC). 
Antibody-<lependent cellular cytotoxicity appears to be a multistep event 
similar to direct tumor cytotoxicity, requiring binding of tumor targets and 
release of cytolytic mediators. However, the method of target recognition and 
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lysis is  different. This mechanism kills neoplastic cells indirectly by recognition 
of the Fc portion of immunoglobulin (IgG) specific for determinants of the target 
cell (3). Direct contact-mediated cytolysis can require 1-3 days, in contrast, 
ADCC can result in tumor cell lysis within 4-6 hours (3,6). 
Other findings have indicated that activation of macrophages for direct 
tumor cytolysis is distinct from activation for ADCC. Peritoneal macrophages 
elicited by BCG in C3H/HeJ and A/J mice, which are genetically deficient for 
the ability to recognize and lyse neoplastic cells respectively, can be activated 
for ADCC (3). This suggests that these two mechanisms differ in both the 
recognition and effector steps (3). 
Nathan and Cohn (81) have suggested that H202 may be the lytic mediator 
of ADCC. It has been shown that anaerobiosis, deprivation of glucose, or 
addition of H202 scavengers such as thioglycollate inhibit ADCC activity (4). 
Binding of macrophage Fc receptors has also been shown to trigger the release of 
large quantities of H2 02 (4,5). These findings seem to indicate a major role for 
oxygen metabolites in A DCC. 
A third function mediated by macrophages against neoplastic cells is target 
cytostasis. When tumor cells are cocultured in the presence of activated 
macrophages they show a reduced rate of cell division (6,30). This cytostatic 
activity can result by blocking DNA synthesis (8 phase) or mitosis in the target 
cell (5,6). 
K eller (54) demonstrated that whether an activated macrophage will be 
tumoricidal or cytostatic is dependent upon the tumor target, as certain tumor 
cells which are more resistant to cytolysis may still be vulnerable to the 
cytostatic mechanism of the activated macrophage. The inhibition of division in 
neoplastic cells can occur as a result of a reversible process or an irreversible 
process which leads to destruction of the cell. The mouse adenosarcoma cell line 
25 
EMT-6 shows a reduction in cell division in the presence of activated 
macrophages. This effect is reversible upon removal of the effector cells from 
culture (5,6). Cytostasis is also manifested in target cells before they are lysed 
by activated macrophages (6). Although the results are similar, the mechanism 
from which these two events arise are quite different. 
The mechanism by which activated macrophages mediate their cytostatic 
effect is not well known. Of the possible cytotoxic substances secreted by the 
activated macrophage thymidine, arginase, prostaglandin (PGE), and interferon 
have all demonstrated anti-proliferative e ffects on neoplastic cells in vitro 
(6,35,97). 
Signal Requirements for Macrophage Activation 
Activation of inflammatory or responsive macrophages for cytotoxic 
activity directed towards tumor cell or microbial targets requires a two stage 
reaction sequence: a priming signal which induces a responsive, noncytotoxic 
state, a.nd a triggering signal which stimulates the macrophage to become 
functionally activated (77). Resident macrophages which are unresponsive to 
activating signals become responsive when cultured for several days (6). 
The priming signal for responsive macrophages has been demonstrated in 
vitro to be supplied by T cell-derived LK(s) known functionally as macrophage 
activating factor (MAF) (6,8). The primed macrophages can then be activated by 
nanogram quantities of endotoxin. Other products such as tumor cell 
supernatant, a low molecular weight serum factor, maleylated protein, and high 
doses of LK can also provide the triggering signal (6). 
While there are obvious similarities in the regulation of tumoricidal and 
microbicidal functions, they may be dissociated according to the regulating 
signals required. T cell LK's appear to have an omnipotent role in functional 
regulation and activation of macrophages (31,89,1 14,138). It has been shown tha.t 
T cells can produce a variety of LK's with distinct physiological influences on 
the macrophage (31). Macrophages have also been shown to be heterogeneous in 
their response to the various LK's (114). Therefore, the use of crude 
supernatants from mitogen- and antigen-,stimulated lymphocytes is of limited 
value in determining the signals and events leading to functional activation. 
Determining the relationship between soluble T cell mediators and the 
regulation of macrophage functions must be approached at a single cell level; 
however, obtaining enough material from a single T-lymphocyte is impossible. 
' When Kohler and Milstein (57) announced that they had immortalized an antigen­
specific, IgG secreting plasmacytoma (P3-X63Ag8) with spleen cells from 
immunized mice, they opened the door for more in-depth stUdies concerning the 
precise nature of T cell-macrophage interactions. 
The techniques for preparing T cell hybridomas is essentially a 
modification of the Kohler-Milstein m ethod for the production of monoclonal 
antibody secreting cell lines but in which helper or suppressor T cells are fused 
with BW5147, a Thy 1.1  positive cell line of A K R  (H-2k) origin. Hybrid cells are 
then cultured in selective HAT medium (DMEM, 10% FeS, 100  llm hypoxanthine, 
10 llM aminopterin, 30 llM thymidine). The BW5147 is deficient in the enzyme 
hypoxanthine guanine phosphoribosyl transferase (HGPRT) and cannot survive for 
longer than 24-48 hours in this medium (57). All cells living at day 1 4  can be 
assumed successful fusions since survival requires the HGPRT gene from the 
spleen cell parent and the genetic information for continuous growth from the 
lymphoma parent (99). Once the hybridomas become established they can be 
screened for the production of the desired lymphokines. Hybridoma technology 
offers a straightforward approach for determining the number and nature of the 
LK's produced by different T cell subsets. T cell hybridomas are a great 
advantage as they provide a defined source of material for functional, 
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biochemical and genetic analysis. 
Hypothesis 
It has been proposed that macrophages in various states of functional 
activation (i.e. resident, responsive, primed, and fully activated) are in different 
stages of the cell cycle. During these stages, the macrophages differ markedly 
in their capacity to respond to LK (11 2,11 3,114). In order to look more precisely 
into the process of macrophage activation and the role of T cell derived LK's we 
have constructed T cell hybridomas. The purpose of this study was to determine 
the role of T cell hybridoma LK's and recombinant Y -interferon in inducing 
different protective mechanisms in various macrophage populations. This was 
done by challenging in vitro with tumor cells, live opportunistic amoebae and 
amoebic or bacterial lysates. Supernatants from T cell hybridoma lines T-3 and 
T-9 were both capable of protecting resident macrophages from Naegleria 
lysates but are unable to elicit a similar response in TG macrophages. Gamma 
interferon treatment did not protect either macrophage population. It was 
further demonstrated that Y-interferon does not protect TG macrophages from 
the destructive effects of the adenylate cyclase enzyme of Bordetella. We have, 
therefore, concluded that protection from the cytopathic amoeba Naegleria 
fowleri and the bacterium Bordetella pertussis is a non- y-interferon induced 
mechanism distinct from the mechanism involved in the destruction of tumor 
cells. 
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MATERIALS A N D  METHODS 
Animals. Eight to ten week old, female C3H/HeN mice (Charles River 
Breeding Laboratories, Kingston, NY) were used in this study as the source of 
resident and thioglycollate (TG) macrophages. 
Peritoneal macrophages. Resident and TG-macrophages were harvested by 
reflecting the skin over the abdomen and injecting 5.0 mls of Hank's balanced 
salt solution (HBSS); Ca++ /Mg++ free) into the peritoneal cavity. After agitating 
the abdomen, cells were drawn off and suspended in HBSS. Cells were 
centrifuged at 500 x g at 250C, washed twice, and resuspended in 10 ml of 
Dulbecco's modified minimum essential medium (DMEM) (Flow Laboratories) + 
10% FCS. Red blood cells were lysed with 5.0 ml tris-buffered NH4CI (pH 7.2). 
TG-macrophages were obtained from mice receiving 1.0 ml (i.p.) of 10% Brewer's 
thioglycollate 4 days prior. 
Tissue culture media. T-cell hybridomas were cultured in DMEM 
supplemented with 10% FCS, 2 mM glutamine, penicillin and streptomycin (100 
�/mI), 4% sodium bicarbonate, and 15 mM HEPES (pH 7.2). Hybridoma T-cell 
lines were also maintained in HBI0l serum-free medium specifically for 
culturing murine myeloma and hybridoma cell lines (Hana Biologics, Inc., 
Berkeley, Calif.). Hybridomas were adapted and maintained in this medium to 
facilitate the isolation and purification of T cell derived LK's. 
T-cell hybridoma culture supernatants. T-cell hybridomas were prepared 
as described by Niederhuber et al. (84). Briefly, lxl07 HAT sensitive BW5147 
thymic lymphosarcoma cells were fused with lxl08 nylon wool purified, ConA 
stimulated splenic T-cells (Fig. 1). Hybrid cells were recloned by limiting dilution 
and screened for their ability to protect adherent resident peritoneal cells 
against the effect of Naegleria cytotoxic factor(s), their ability to increase 
tumor cell cytolysis by TG-elicited macrophages, and induction of Ia antigen 
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expression in TG-elicited macrophages after 24 hr of treatment. When used for 
lymphokine production, T cell hybridomas T-3 and T-9 were seeded at either 
1x106 cells/ml in DMEM + 10% FCS or 6x104 cells/ml in HB101 serum free 
media. Supernatants were collected after 24-48 hr by centrifugation at 500 x g 
for 1 0  min at 4oc. 
Determination of hybridoma division time. T-cell hybridomas were maintained 
at 1x106 cells/ml in DMEM + 1 0% FCS. Total cell number per flask was 
determined at 24, 48, and 72 hr. 
IL-2 assay. IL-2 dependent, C10 cells (lx104 cells) were cultured for 24 hour 
along with serial dilutions of T-3 and T-9 supernatants in flat bottom tissue 
culture plates. C10 were also cultured in TCGF conditioned medium or DMEM 
as positive and negative controls. The cells were then pulsed with 1IJCi 3H-TdR 
for an additional 24 hour. Wells were harvested using a MASH cell harvester and 
assayed using a liquid scintillation counter. 
Induction of hybridoma derived LK. In an attempt to maximize the production of 
LK from hybridomas T-3 and T-9, cells were incubated at various densities 
(2.5x104, 5x104, 1x105m 5x105) with or without 5IJg ConA. At 24 and 48 hr, 5.0 
ml of supernatant was collected and the ConA was absorbed out of the 
supernatants by adding G-25 sepharose beads and centrifuging at 1000 x G for 1 0  
m in. Con A-free supernatants were then collected. The amount of LK produced 
was reflected as the percent cytostasis induced by the supernatants in TG­
macrophage (cytostasis assay was performed as described earlier). 
Macrophage-mediated destruction of Naegleria fowleri. Resident macrophages 
(2 x 1 05) were incubated along with diluted T-3 or T-9 supernatants (1:1, 1 :2, 
1 :8). After 24 hrs, 2 x 104 3 H -uridine labelled !!. fowleri target cells (which 
had been cultured with 51J Ci 3 H -uridine 24 hr prior) were added. After an 
additional 2 4  hr, 100 III of each culture supernatant was 
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removed and added to 3 m l  o f  Beckman redi-solve scintillation fluid. All samples 
were run in triplicate and assayed using a liquid scintillation counter (2 min, 2 %  
error). 
ASsay for macrophage protection against Naegleria fowleri lysate. Naegleria 
lysates were provided by Dr. Francine Marciano-Cabral (Department of 
Microbiology and Immunology, Medical College of Virginia) and were prepared by 
freeze-thawing using a dry ice - EtOH bath, followed by submersion in a hot 
water bath for 30 sec. After freeze-thawing 4 times, the amoebae were 
sonicated for 3, one min intervals. Resident and thioglycollate-recruited 
macrophages were cultured at 3x105, 1 .5x105, and 3x104 cells/ml along with 
3x104 equivalents of crude !i. fowleri lysate (lysate equal to 3x104 live 
Naegleria), and either recombinant y -IFN, T-3, or T-9 at 370C and 5% C02' At 
the end of 18 hr, the macrophages were pulsed for 2 hr with 50 \.11 (5 \.ICi) of Na2 
51Cr04' The wells were washed 3 times to re move unbound 51Cr and then 100  J.I1 
of I N  NaOH was added and incubated for 5 min at room temperature. This was 
repeated once again and then samples were radioassayed using a LKB gamma 
counter (all samples were run in triplicate). 
Assay for macrophage protection against Bordetella pertussis lysates. Resident 
and TG-macrophages were cultured at 3x105, 1 .5x105, and 3x104 cells/ml along 
with lysates from Bordetella strain BP338 (wild type) (45 J.Ig protein/ml) and 
recombinant y -IFN. After 18 hr, macrophages were pulsed for 2 hr with 50 JJl 
(5J.1Ci) of Na251Cr04' The wells were washed three times to remove unbound 
51Cr and then 100 J.I1 of 1 NaOH was added and incubated for 5 min at room 
temperature. This was repeated and samples were radioassayed using a LKB 
gam ma counter (all samples were run in triplicate). Bordetella lysates were a 
gift from Alison Weiss (Department of Microbiology, University of Virginia, 
Charlottesville). 
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Tumoricidal assay. The activation of resident or TG-elicited macrophages for 
tumoricidal activity was determined using the C3H/HeJ fibrosarcoma, L929, as 
target cells (67). Adherent peritoneal exudate cells (5x105) were placed into 2 4  
well tissue culture plates with dilutions o f  T-3, T-9 or Y -IFN. After 24 h r  the 
wells were washed twice with warmed media and cultured with 5x104 3H -TdR 
labelled L929 target cells. After an additional 24 hrs, 5 llg DNase was added 2 0  
m in prior t o  harvesting the supernatants to facilitate the release o f  radioactivity 
from killed target cells (129) and 0.5 ml of each culture supernatant was 
removed and then placed in 10 ml of Beckman redi-solve scintillation cocktail. 
All samples were run in triplicate and assayed using a liquid scintillation counter 
(2 min, 296 error). 
Induction of macrophage-mediated tumor cell cytostasis. Diluted supernatants 
from T-3 and T-9, or cloned Y-IFN were compared for their ability to activate 
resident or TG-elicited macrophages for tumor cell cytostasis. Adherent PEC's 
(1x105) were either incubated for 24 hrs with LK or LK was added 
simultaneously with the addition of 1x104 B16F10 melanoma target cells. After 
an additional 24 hrs, the cells were washed twice with warm DMEM and the cells 
were pulsed for 24 hours with 1 \1Ci 3H-TdR. Wells were harvested using a 
M ASH cell harvester and assayed using a liquid scintillation counter (2 m in, 296 
error) (53). Percent cytolysis was calculated by the formula: 
Cytostasis (96) = experimental CPM X 100 
control CPM 
Experimental CPM: B16F10 target cells and macrophage; control CPM: B16F10 
tumor cells in the absence of macrophage. 
Kinetics for the induction of tumor cell cytostatic activity by LK. Adherent, 
thioglycollate-elicited macrophages (1x105) were added in 100\11 to 96 well 
plates. Macrophages were treated with 1 :10 dilutions of T cell hybridoma 
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supernatants (T-3 or T-9) or IOU of cloned y -IFN for 0, 6, 1 2, 18,  and 24 hr. At 
the end of each incubation period, 1 x 104 B16F10 melanoma target cells were 
added. After an additional 24 hr incubation, the cells were given 24 hr pulse 
with 3 H-TdR (lIlCi/well) and assayed as described. 
Induction of Ia-antigen expression. The T-cell hybridoma supernatants were 
screened for their ability to induce la antigen expression using 
immunofluorescence. TG elicited PEC's (Sx10S cells/100 Ill.) were adhered on 
glass slides and fixed for I S  min using 1 % paraformaldehyde. Macrophages were 
then washed in DMEM (S% rabbit serum) and after 20 min fresh DMEM (S% 
rabbit serum) containing a 1 :80 dilution of the monoclonal antibody 10-2.16 (anti­
I-Ak) was added for 40 min at 40C. Unbound antibody was removed by washing 
twice with cold media. Next, media containing a 1 :30  dilution of fluorescein­
conjugated goat-ant i-mouse antibody (heavy and light chain specific) was added 
at 40C for an additional 40 min. Cells were again washed twice to remove any 
unbound antibody and analyzed using epiilumination. 
Determination of ectoenzyme profiles. Resident or TG-LK-treated macrophages 
(lx106) were lysed in 1 .0 ml of O.OS% triton X-100 and then frozen at -200C. 
Alkaline phosphodiesterase I (APD-I) activity was determined by taking 100 III of 
the macrophage lysates and aliquoting into disposable glass 1 2x7S mm tubes 
along with the substrate, loS m M  p-nitrophenyl thymidine-S'-monophosphate 
(prewarmed to 370C). The samples were mixed well, covered with aluminum foil 
to protect from light, and then incubated at 370C water bath. After 30 min the 
sa mples were placed on ice and the reaction stopped by the addition of 1 .0 m of 
0.1 N NaOH and vortexed. Absorbances were determined using a Beckman 
spectrophotometer at 400 nm (24). To determine S' nucleotidase activity (S'N), 
SOO III of 0.018 mM 3H -AMP substrate was added to 100 III of macrophage 
lysate and incubated at 370C in a water bath, shaking every 10 min. After 30 
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min the samples were placed on ice and the reaction stopped by adding 200 \.ll of 
0.25 M ZnS04 and vortexed, followed by the addition of 2 0 0  III 0.25 M Sa (OH)2 
and vortexing once again. Samples were then centrifuged at 1000 x g for 30 min 
after which 500 III of the supernatant was added to 1 0  mls of Beckman redi-solve 
scintillation fluid and each sample was counted in a Beckman scintillation 
counter (23). Resident and TG-macrophages were then compared for changes in 
API and 5'N activity. 
Transferrin binding. Transferrin was iodinated using enzymobead reagents 
(Biorad). Briefly, transferrin was radioiodinated with lactoperoxidase and 
glucose oxidase coupled to agarose beads according to the manufacturer's 
instructions. Na1 2 5I (LO rn cn was added to the reaction along with the protein 
to be labelled. The reaction was allowed to proceed for 2 5  minutes at RT and 
then the contents of the vial were placed on a Sephadex G-25 column and 
centrifuged at 100  x G for 2 minutes. The effluent was collected in a 
polystyrene test tube and diluted with 1.0 ml of PBS and 2lIi was counted in a 
LBK gamma counter to determine the CPM/llg protein. A TCA precipitation was 
done to determine the efficiency of labelling. To assay for transferrin binding, 1 
x 106 resident or TG-macrophages were cultured in 24 well plates in DMEM 
alone or in the presence of Y -IFN, T-3 or T-9. After 24 hr wells were washed 
twice with Hanks (BSA 1 mg/ml). 125I-Iabelled transferrin (2 nmoles) was then 
added to 1.0 ml Hanks buffer along with a 1000 fold excess of unlabelled 
transferrin. Plates were incubated at 40C for 1 hr and then washed twice with 
buffer. This was followed by the addition of 0.1 N NaOH (0.5 ml) which was 
allowed to stand overnight at 40C. Results were determined using a LKB gamma 
counter. All samples were run in triplicate. 
Recombinant Y -interferon. The recombinant mouse Y -IFN used in this study 
was generously supplied by Patrick W. Gray (Genetech, South San Francisco, 
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CA), and was produced from monkey C05-7 cells transfected with a plasmid 
containing the murine Y -IFN gene expressed under control of the SV40 
promoter. Supernatants contained 19,000 units/ml as determined in a cytopathic 
effect inhibition assay using encephalomyocarditis virus on L929 murine 
fibrosarcoma cells (33). 
Anti-y-interferon. The rabbit anti-mouse y-IFN was a gift from Howard M. 
Johnson (Dept. of Comparative and Expt. Pathology, Univ. of Florida, 
Gainesville) and was produced by stimulating spleen cells with staphylococcal 
enterotoxin A as described earlier. The serum titer used in this study contained 
antibody sufficient to neutralize 1,000 units of 'f-IFN/ml (88). 
Neutralization studies. The effects of anti-y-IFN on LK activation of TG­
elicited macrophages for B16F10 tumor cell cytostasis was determined. Diluted 
supernatants from T-3 and T-9 (1 :5, 1 :10, 1 :20)  were added to 1x105 adherent 
PEC's along with antibody sufficient to neutralize 10 U of y-IFN activity. After 
24 hr lx104 B16F10 melanoma target cells were added and the ability of anti-y ­
IFN to inhibit macrophage cytostatic activity was determined. 
Molecular characterization of T-3 and T-9. In order to establish the protein 
nature of the LK's, supernatants were incubated at 5 60C, for 3 min, 800C or 
1000C for 5 m in. Supernatants were also treated with 6.5 units of immobilized 
Q-chymotrypsin (Sigma) for 1 hr. Treated supernatants were then assayed for 
cytostatic activity. The molecular weight range of T-9 was determined using an 
Amicon filtration system. Using a ym30 (mw. cut off 30K) and a ym10 (mw. cut 
off 1 0 K) filter, three fractions were collected: (a) � 3 0,000, (b) 2 10,000 ::. 30,000, 
(c) .:: 10,000. These fractions along with unfractionated supernatant were then 
assayed for cytostatic activity. 
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RESULTS 
Screening of T-cell hybridomas. Supernatants from the T-cell hybridomas were 
collected and initially screened for their ability to protect against the cytotoxic 
effects of Naegleria lysate, increase tumoricidal activity, and induce Ia-antigen 
expression in resident and TG-macrophages. 
Supernatants from 5 of the 16 cloned cell lines (T-2, T-3, T-6, T-9, T-13) 
were able to significantly lower Naegleria lysate induced cytotoxicity in resident 
macrophages (Fig. 2A). Supernatants from clones T-2, T-3, T-6, and T-1 3 
induced tumoricidal activity in TG macrophages, while this population appeared 
to be unresponsive to T-9 supernatants (Fig. 2B). Only three (T-3, T-9, T-13) of 
the original clones with activity protecting against Naegleria lysates also 
induced Ia antigen expression in TG-macrophages (Fig. 2C). Based on thse three 
activity patterns were selected T-3 and T-9 for further characterization. 
T-3 and T-9 were both maintained in DMEM and 10% FCS and gradually 
adapted to HB101 serum free medium. Both clones continued to produced 
sufficient LK in either media (serum-free supernatants were designated 3HB and 
9HB). 
T-cell hybridoma division times. Both hybridomas T-3 and T-9 were observed to 
double in number every 24 hr. Cell number increased from the initial 1x106 
cells/ml to 1.8x106 after 24 hr, 4.1x106 cells/ml at 48 hr, and 12.8x106 at 72 hr. 
(Fig. 3). The growth of both T-3 and T-9 was particularly density dependent 
which may explain why cellular division proceeded at a slightly increased rate 
between 48 and 72 hr. 
IL-2 determination. None of the culture supernatants screened contained any IL-
2 activity relative to the positive controls containing TCGF (Table 1). At all 
three dilutions, one of the T cell supernatants were able to induce a proliferative 
response as determined by the uptake of 3H-TdR. 
Fig. 2. Screening of cloned T cell hybridoma supernatants. A. Protection 
of resident macrophage agai�t destruction crude Naegleria fowleri 
lysate. Adherent peritoneal macrophage (3 X 1 05) were co-cultured with 
3 X 1 04 equivalents of crude lysate and a 1 :2 dilution of crude hybridoma 
supernatants. After 18 hr, macrophage were given a 2 hr pulse with 
Na251Cr04' Unbound 51Cr was washed free and viable macrophage were 
lysed in I N  NaOH. Triplicate samples were assayed using a LKB gamma 
counter. B. Activation of TG-elicited peritoneal macrophage for 
tumoricidal function. TG-macrophage were cultured 24 hr with 1 :10 
dilution of the hybridoma supernatants. Supernatants were removed and 5 
X 104 3 H -TdR labelled L929 cells were added for an additional 24 hr. 
Prior to harvesting 5 J..lg DNase was added and then 0.5 ml of culture 
supernatant was assayed. Results are presented as percent 3 H -TdR 
released. C. Induction of la-antigen expression. TG-macrophage (5 X 
105/100  Ill) were treated for 24 hr with hybridoma supernatants and then 
adhered to glass slides and fixed in 1% paraformaldehyde. Macrophage 
were washed and a 1 :30 dilution of a monoclonal antibody 10-2.16 (anti-I­
Ak) was added, followed by the addition of fluorescein-conjugated goat­
anti-mouse antibody (diluted 1 :30).  Cells were analyzed using 
epiilumination and expressed as 96 of total population expressing Ia 
antigen. 
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Table 1 .  Assay for IL-2 activity in T cell hybridoma supernatantsa 
CPM +/-S.D. (% v/v condition media) 
SAMPLES MEDIA 50  25 12.5 6.25 
1-4 3 Sb 334  + 99  585  + 195 798 + 301 391 + 70 
5-8 3 HBc 348 + 84 357 + 19 405 + 73 51 + 290 
9-12 9 S  240 + 48  429 + 108 474 + 55 518 + 155 
13-16 9 HB 868 + 46  912  + 150 943 + 218  887 + 159 
17-20 TCGF 12355  + 2 38 15315 + 736 19372 + 1808 13656 + 1027 
21 none 279 + 109  
aIL-2-dependent C10 cells were cultured at  1X104 along with serial dilutions of 
T-3, T-9, or TCGF. Cells were pulsed with 1 \lCi 3 H -TdR for an additional 24 
hr and then harvested on a M ASH cell harvester and assayed using a liquid 
scintillation counter. 
bSupernatants were obtained from cultures grown in DMEM + 10% FCS. 
cSupernatants wre obtained from cultures grown in HB101 serum-free media. 
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Induction of hybridoma-derived LK. While it has been demonstrated that the 
addition of Con A to hybridoma cultures can increase production of LK (84), this 
was not the case for T-3 or T-9. The addition of ConA did not result in any 
significant differences when compared to untreated cultures. Dilution of the 
supernatants did not show any differences in the cytostatic activity induced in 
the treated macrophages. Both the treated and untreated supernatants produced 
maximum cytostatic activity at 1 :10 and 1:20 dilutions (Fig. 4). The length of 
exposure to ConA did not effect LK production as treatment for 24 hr (data not 
shown) or 48 hr yielded similar results. Varying the cell number also did not 
produce a differential response to ConA (data not shown). 
Macrophage protection against Naegleria fowleri. The ability of T-3 and T-9 
supernatants to protect resident macrophages against the cytopathic effects of 
live Naegleria and Naegleria lysates were compared. Resident macrophages 
resulted in the specific release of less than 10% of the 3 H -uridine labelled 
Naegleria in the absence of LK. When cultured in the presence of T-3 or T-9, 
resident macrophages mediated the speCific release of 42% and 43% of the 3H -
uridine label respectively (Fig. 5) (spontaneous release was les than 6%). T-3 and 
T-9 LK's also protected resident macrophages from destruction by Naegleria 
lysates. Resident macrophage destruction was decreased by 15% and 24% upon 
the addition of T-3 or T-9 supernatants (Fig. 6). The cytostatic activity (anti­
proliferative effect as determined by 3H -TdR uptake) in the same population of 
resident macrophages towards B16F10 target cells however was low. This 
activity could not be increased by the addition of T-3 or T-9 supernatants (data 
not shown). 
Cloned y-IFN was unable to offer similar protective mechanism to resident 
macrophages. Ten units, of y -IFN had no effect on cytotoxicity in lysate-treated 
resident macrophages. Regardless of the target/effector ratio (resident 
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F ig. 6. Effect of T cell hybridoma-derived LK on the destruction of 
ma crophage by Naegleria fowler i  lysates. Resident macrophage were 
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M a cr ophage were pulsed w i th 2 hr w i th 54 C i  5 1 Cr/well. Unbound 5 1 Cr 
w as washed free and viable cells lysed in  1 N  NaOH. Triplicate sa m ples 
were assayed using a L K B  ga m ma counter. 
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macrophages: Naegleria equivalents), Y -IFN did not appear to influence their 
vulnerability to Naegleria lysates (Table 2). Thioglycollate�licited 
macrophages were also sensitive to the cytotoxic effect of lysate and as seen 
with resident macrophages, the addition of Y -IFN was unable to prevent their 
destruction. (Table 2). Unlike resident macrophages, which were not activated 
for tumor cell cytostasis by LK (T-3, T-9, Y -IFN), Y-IFN treatment of TG­
macrophages resulted in increased activity directed against B16F10 melanoma 
cells (Table 3). 
Macrophage protection against Bordetella pertussis. The ability of recombinant 
Y-IFN to protect TG-macrophages against the cytopathic effects of Bordetella 
pertussis (strain BP338) lysates was also determined. At all target (TG­
macrophages)/effector (BP338 lysates) ratios tested, Y -IFN was unable to offer 
protection (Fig. 7). Both Y -IFN-treated and untreated macrophages were equally 
susceptible to the cytopathic effects of lysates. This observed destruction of 
TG-macrophages by BP338 lysates is density dependent. Using 3x105 
macrophages, 57% of the untreated macrophages and 51% of the Y -IFN-treated 
macrophages were killed. This increased to 69% and 66% respectively with 
1 . 5x105 macrophages and 90% and 92% using 3x104 cells. 
Kinetics for the induction of cytostatic activity by T cell LK. In order to 
determine the exposure time to T-3 and T-9 required to produce maximal 
cytostatic activity, TG-macrophages were exposed to LK for various time 
periods between 24 and 48 hr. All macrophages were exposed to target cells for 
the same period of time (24 hr). Exposure of macrophages to LK for 24 hr 
induced cytostatic activity in TG-macrophages (Fig. 8). This activity remained 
constant over the next 48 hr, as further exposure was unable to increase activity. 
Alteration of ectoenzyme profiles. Several investigators have associated plasma 
membrane ectoenzyme levels with differentiation or activational changes in 
Table 2. Effect of recombinant 't-IFN on the destruction of macrophage by 
Naegleria fowleri Lysates 
%Macrophage Destruction (51Cr Uptake) 
Macrophage/ 
Naegleria Equivalentsa 
3XI0 5/3 XI04 
1.5XI05/3XI04 
3XI04/3 XI04 
Resident Macrophal!:e 
medium HFN (10 U) 
21 + 15b 17 + 12 
22 + 12 29 + 8 
26 + 6 15 + 7 
Thiogl;icollate Macrophage 
medium Y-IFN (10 U) 
20 + 4 14 + 3 
22 + 8 23 + 3 
30 + 12 26  + 7 
aMacrophage were cocultured with Naegleria lysates for 18 hr, pulsed for 2 hr 
with 5jJCi of 51Cr, and lysed with 1 N NaOH. 
bMean + standard deviation. 
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Table 3. Enhance ment of tumor cell cytostasis by recombinant Y-IFN 
% Cytostasis ( 3 H -Tdr Release) 
Resident Macrophage Thioglvcollate Macrophage 
Macrophage/Bl6 Fl oa medium 'f-IFN (10 U) medium Y-IFN (10 U) 
l X 1 0 5/1 X104 1 1  + 5b 0 66 + 9 76 + 3 
5 X I 04/1XI04 0 18 + 1 64 + 1 80 + 1 
l X 1 04/1X104 0 0 1 8  + 1 0  78 + 2 
aMacrophage were treated with recombinant 'f-IFN for 24 hr and wells were 
washed 3 X  to remove excess LK prior to the addition of B16FI0 target cells. 
Cultures were incubated an additional 2 4 hr followed by a 24 hr pulse with 
I 11Ci 3 H -TdR. Wells were harvested using a MASH cell harvester and asayed 
using a liquid scintillation counter. 
bMean + standard deviation. 
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macrophage populations and have de monstrated changes in the ectoenzyme 
levels in tu moricidal macrophages (19,21,70). We therefore chose to determine 
the effects of T-3 and T-9 on A PD-I and 5'N activity. Resident macrophages 
initially had lower APD-I activity but higher 5'N activity as compared with TG­
macrophages. After treatment with T-3 or T-9 for 24 hr there were no 
significant changes in APD-I or 5'N levels in either macrophage population (Fig. 
9, 10).  
Because T-3 exhibited the capability to induce tumor cell cytotoxicity and 
cytostasis, protect against the cytopathic effects of Naegleria fowleri lysates, 
and induced Ia expression, but did not alter ectoenzy me profiles at 24 hrs, we 
decided to observe the kinetics of T-3 modulation of ectoenzyme levels in 
resident-macrophages (Fig. 1 1 ,  1 2). Alkaline phosphodiesterase I activity was 
observed to decrease during the first 4 hrs. Between 4-12 hrs there was an 
increase in T-3 treated cells, while activity continued to decrease in untreated 
resident-macrophages. At 24 hrs, activity levels were not significantly higher 
than the untreated controls. 
The 5'N activity was also observed to decrease rapidly in T-3 treated and 
untreated resident macrophages during the first 4 hrs. Activity leveled from 4-
1 2  hrs, but continued to decrease in both treated and untreated cells. 
Expression of transferrin receptors. Recent findings have shown that the 
expression of transferrin receptors m ay be a useful marker of the responsive 
stage for macrophage functional activation (37,131). For this reason we wanted 
to determ ine the effects of T-3 and T-9 supernatants on the number of 
transferrin receptors. We found TG-elicited macrophages initially bound 
significantly higher quantities of 125I-transferrin compared to resident 
macrophages (Table 4). Untreated resident macrophages bound 17 pi co moles of 
transferrin. When treated with T-3 or T-9 the number of pico moles bound 
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Fig. 1 0. Effect of T cell hybridoma ly mphokines on 5 'nucleotidase 
a c t i v i t y .  Resident and T G-recr uited ma crophages were t reated with 1 :1 0  
diluti ons o f  T -3 o r  T -9 hybr idoma supernatants containing seru m (3 ,9 )  or 
without seru m  (3HB,  9 H B). After 2 4  hr, 1 X 1 0 6 cells w ere lyse d in 1 . 0  ml 
of 5 ck;, triton X -I 0 0 .  5 'nucleot idase levels w e re determ ined as descr ibed in 
il1 a t e r ials and :'I1ethods. 
5 3  
� 
4> E F F E C T S  O F  H Y B R I D O M A  - D E R I V E D  -0 
� L Y M P H O K I N E S  O N  A L K A L I N E  D-
Ol P H O S P H O D I E S T E R A S E  I A C T I V I T Y  E 6 I N  R E S I D E N T M A CROPHAGE -
� 
E 
- 5 In * R M 0  4> 
0 Y R M.0 .. 3 
E " 
o R M .0  .. 3 + L P S  
� 
> 
� 3 
> 
� 
() 
< 2 
() 
IL. 
() *----------UJ � C/) * 
0 
4 8 1 2  1 6  2 4  
Fig. 1 1 . Effects of hybridom a--<lerived lymphokines on alkalhe 
phosphodiesterase I a ctiv ity in resident macrophages over 24 hr. Reside:1t 
macrophages were t reated for 4, 8, 1 2, 1 6 ,  and 24 hr with 1 :1 0  d ilutions of 
T-3 supernatant (w ith or w i thout 5 �g LPS). A fter the speci fied peri0:i5, 
I X I 0 6 cells were lysed in 1 . 0  ml of 0 . 0 5 %  triton X-I O O  and assayec !1S 
described in Materials and M e thods. 
E 
II> 
0 
� 
Q 
0-
E 
'-
c 
E 
'-
V: 
<I> 
0 
E 
c 
>-� 
> 
� 
u 
< 
u 
!::: 
u w c.. (/) 
1 5  
1 0  
5 
0 
E F F E C T  O F  L Y M P H O K I N E 3 O N  
5 '  N U C L E O T I D A S E  A C T I V I T Y  
I N  R E S I D E N T  M AC R O P H A G E  
4 8 1 2  
T I M E  ( h r s . )  
. R M0' 
. R M0' + 3 
o R M0' + 3 + L P S 
1 6  2 4  
Fig. 1 2 . Effect o f  T-3 derived lymphokine on 
5 'nu cleotid9.Se activity in 
reside ;) t  macrophage over 24 hr. Resi
dent macrophage w ere treatec for 
4, 8 , 1 2, 1 6 , 2 4  hr w i th 1 :1 0  dilut ions of T-3 supern
atant ( w i th or wi t�:>ut 
5 �g LPS). After the speci fied periods, 1 X I 0
6 cells were lysed in 1 . 0  ml of 
0. 0 5 '*  t riton X -1 0 0  and assayed as  des
cr ibed i n  ;\1ate rials and ;\'J et hods. 
54 
Table 4. Transferrin binding by resident and 
thioglycollate-elicited peritoneal macrophage a 
Transferrin Bound (pico moles) 
Treatment Resident Macrophage Thioglycollate Macrophage 
medium 1 7.4 + 0.5 26.1 + 1.6 
T-3 2 4.6 + 0. 7  27.1 + 1.8 
T-9 2 1 .0 + 2.4 31.3 + 0.1 
Y-IFN 13.4 + 0.9 2 3.4 + 1.3 
aTransferrin binding was determined in the presence of 2.0 n moles 1 2 51_ 
labelled and 2000  nmoles of unlabelled transferrin after 1 hr cells were 
washed 3 times and lysed in O.l N  NaOH. 
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increased to 25 and 21 respectively. Gamma-IFN induced a slight decrease in 
the number of moles bOWld by resident macrophages. When TG-macrophages 
were treated with T-3, no significant increase was observed in transferrin 
binding. However, elicited macrophages treated with T-9 showed an increase in 
the number of transferrin receptors and bound 31 pica moles. As seen with 
resident macrophages, Y -IFN produced a slight decrease in the number of moles 
of transferrin bOWld. 
Serological characterization. Antibody capable of neutralizing the anti-viral 
activity of 1 0  Wlits of Y -IFN was able to neutralize a 1 :5 dilution of T-9 
supernatant and prevent the induction of cytostatic activity in TG-macrophage 
populations against B16F10 melanoma cells. While inducing a 37% increase in 
activity over the media control, T-9 activity was reduced to les§ than 20% in the 
presence of anti-Y-interferon (Fig. 1 3). T-3 supernatants appeared relatively 
unaffected by antibody, maintaining high levels of activity ( 55%), 
demonstrating that the activity contained in T-3 supernatants is due to a Wlique, 
non-gam ma-IFN molecule. 
Characterization of lymphokine activity. A standard cytostatic assay, utilizing 
TG-macrophages and B16F10 melanoma target cells, was used to determine the 
heat stability and molecular nature of T-3 and T-9 LK. Treatment of 
supernatants at 560C for 3 0  min did not effect T-3, but eliminated the ability of 
T-9 to induce cytostatic activity in TG-macrophages completely. Incubation at 
800C for 5 min lowered T-3 activity to less than 1 0% and at 1000C for 5 mins all 
activity was lost (Fig 14A). Both T-3 and T-9 were totally inactivated by (l ­
chymotrypsin (Fig. 1 4B). T-3 and T-9 increased tumor cytostatic activity in TG­
macrophages by approximately 38-40% as compared to the medium control. 
After proteolytic treatment neither supernatants showed any activity. The 
cytostatic activity of T-9 LK was fOWld in two amicon filter separated fractions. 
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Fig. 13.  Neu tralization of T cell hybridoma derived ly m phokines by 
ga m m a  i nterferon specific antibody. TG-macrophage (1 X 105) were 
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Fig. 14. Characterization of T cell hybridoma derived lymphokines. 
A. Heat inactivation of T cell hybridoma derived lymphokines T-3 and T-
9. Supernatants from T-3 and T-9 were incubated at 560C for 30 min, 
800C or 1000C for 5 min. After heat treatment supernatants were 
assayed for their ability to induce tumor cell cytostasis in TG-elicited 
macrophages as described in Materials and Methods. B. Proteolytic 
inactivation of T cell hybridoma derived lymphokines T-3 and T-9. 
Supernatants were treated with 6.5 units of immobilized a-chymotrypsin 
for 1 hr. Carboxymethyl cellulose beads were removed by centrifugation 
at 400 x g for 30 min. Treated supernatants were then assayed for the 
induction of cytostatic activity in TG-macrophages. C. Molecular weight 
determination of T-9 derived lymphokine. Supernatant from T-9 hybrids 
grown in HB101 serum-free m edium were fractionated using an Amicom 
filtration system and a ym 30 (mw. cut off 3 0K) and a ym10 (mw. cut off 
10K). Three fractions were collected: (a) � 30,000 (b) 2. 10,000 ::.. 30,000, 
and (c) :.. 1 0,000. These fractions were screened for the induction of 
cytostatic activity in TG-macrophage. 
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Both the 10-30,000 molecular weight fraction and the less than 10,000 fraction 
contained activity comparable to the unfractionated sample. The greater than 
30,000 fraction showed no activity (Fig. 14C). 
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DISCUSSION 
The role of T cell derived lymphokines as modulators of macrophage 
phenotype and function is well documented (13,103,1 13). We chose to screen our 
hybridoma supernatants based on known Y-IFN activities: the ability to increase 
tumoricidal activity and the expression of Ia antigens in peritoneal exudate 
macrophages. Purified Y -IFN has been shown to increase Ia expression in a 
concentration dependent fashion (10,105,1 19,128), while Cl-IFN and � -IFN result 
in minimal increased Ia expression (96,105,137). Cloned or hybridoma�erived Y ­
IFN has also been well documented to prime murine macrophages for tumoricidal 
activity (16,33,89). While Cl-IFN/� -IFN also show tumoricidal activity, y-IFN has 
been reported to be approximately 850-1,000 times more effective at activating 
macrophages (89,95). Earlier findings, that mouse peritoneal macrophages co­
cultured with the opportunistic pathogen, Naeglerill fowleri were killed within 18 
hours, ( Marciano-Cabral, unpublished data) lead us to screen our supernatants for 
LK's that would offer protection. 
Macrophage activation as determined by screening, appeared to correlate 
with the dilution of supernatant; however, it was important to maintain the 
grown of T-3 or T-9 in log phase and with high viability (80%) to insure maximal 
and consistent production of LK. Both hybridoma cell lines demonstrated 
doubling times of 1 8-24 hr and were constituitive producers of lymphokines as 
indicated by the inability to increase LK production by stimulation with Con A. 
Supernatants were also screened for IL-2 (TCGF) production. Neither T-3 or T-9 
demonstrated any IL-2 activity as determined by their inability to induce a 
proliferative response in the IL-2 dependent CI0 cell line (Table 1). 
Functionally, the activation of macrophages has been defined in terms of 
microbicidal and tumoricidal activity (31,37,47,61). Recent attempts have been 
made to define discrete stages of activation. The terms resident, responsive, 
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primed and fully activated have been employed to describe the level of 
activation with regards to tumoricidal activity, and the method of elicitation 
(37,47). 
These macrophage have been shown to exhibit biochemical markers 
justifying this categorization (13,37,47,70,102). We have found that resident and 
TG-elicited peritoneal macrophages responded quite differently to T-3 and T-9 
supernatants when examined for cytostatic and cytotoxic activity directed 
towards tumor cell targets. Both T-3 and T-9 were capable of inducing tumor 
cytostatic activity in TG-macrophages but not in resident macrophages 
populations. While T-3 activated TG-macrophages for tumoricidal functions (but 
not resident macrophages), T-9 was inactive in both macrophage populations. 
Kinetic stUdies using B16FI0 melanoma target cells show that development of 
cytostatic function in TG-elicited macrophages requires approximately 24 hr of 
exposure to LK (T-3, T-9, or Y -IFN). While the level of activity achieved 
appears to vary according to the LK employed and the length of exposure, it is 
difficult to determine whether this is due to the intrinsic nature of the molecules 
(as seen between Q-, a -, and y-IFN) or because of variability in LK secretion by 
the hybridoma cultures. However, we attempted to avoid the latter possibility 
by pooling supernatants. 
The finding that both T-3 and T-9 were capable of inducing protective 
mechanisms against Naegleria lysates in resident but not in TG-macrophages 
offers more evidence of functional differences between these populations. The 
inability of cloned Y -lFN to protect either resident or TO macrophage supports 
the finding that MAF (Y-IFN) inducing tumoricidal activities are different from 
those inducing anti-parasitic activities (51,13 5). 
A dissociation between tumor cytostatic and bacteriocidal mechanisms has 
also been shown (31,61 ). We, therefore, decided to look at the ability of Y -IFN to 
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protect TG-macrophages from Bordetella lysates. !!. pertussis, strain BP338 
(wild type), contains high levels of adenylate cyclase. This enzyme is thought to 
impair host defense mechanisms by entering phagocytic cells and converting ATP 
into cyclic A M P, a known inhibitor of phagocytosis (17). Results were similar to 
those obtained in the Naegleria model with Y-IFN unable to prevent TG­
macrophage destruction. 
A recent report indicates that human T cell clones, specific for a purified 
Mycobacterium tuberculosis antigen, release a form of MAF which is not 
neutralized by monoclonal antibody against Y -IFN (8). Others have shown that 
at high concentrations, recombinant Y -IFN failed to prevent the 
intra macrophage replication of M. tuberculosis and actually caused increased 
mycobacterial replication and macrophage destruction (21). 
The cytopathogenicity of Naegleria fowleri for a variety of mammalian 
cells in vitro has been demonstrated (64); however, the mechanism by which the 
amoeba exerts this effect remains an enigma. It has been suggested that B.. 
fowleri ingests target cells by phagocytosis or by drawing in small portions of the 
target cell plasma membrane until the integrity of the membrane is disrupted 
(64). Other investigators have suggested that a cytopathic toxin or enzyme 
(phospholipases) are released (19,122). Most investigators are in agreement that 
some type of cell contact is required for target cell injury (64,122). 
We have found that live Naegleria and lysates were able to mediate a 
cytopathic effect in both resident and TG-macrophages in an 18-hr assay. These 
findings suggest the presence of a cytotOXiC factor(s) which is either present on 
the membrane surface or is secreted from lysosomes or vesicles upon contact 
with target cells. Curson et al. (19) has shown that phospholipase 2-
lysophospholipase enzymes are found in the supernatants of axenic ally grown B.. 
fowleri and that hyperimmune rabbit antisera prepared 
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against these enzymes could prohibit or delay the cytopathic effects of live 
Naegleria in Vero cell cultures. 
It is particularly interesting that a unique non-gamma interferon L K  
(derived from T-3 and T-9) is capable of protecting resident macrophages from 
Naegleria lysates but does not alter the effects on TG-macrophages. The 
observed change in susceptibility does not involve APD-I or S'N ectoenzyme 
expression since we did not detect any significant changes in the levels of these 
ectoenzymes in treated and untreated macrophage populations over 24 hr. It is 
possible that T-3 and T-9 induce the modulation of a receptor for the cytolytic 
substance from the surface of resident macrophages while not affecting TG­
macrophages. 
This difference in responsiveness to LK could also be due to the particular 
stage of the cell cycle in which TG-macrophages and resident macrophages are 
found. Sorg et al. (112 ,113,1 14) has suggested that as macrophages differentiate 
from bone marrow precursors in the presence of CSF (colony stimulating factor) 
there is an intense phase of proliferation. Some macrophages continue to cycle 
and accumulate in late Gl' These macrophages are functionally capable of 
responding to a wide variety of LK and chemotactic factors as well as producing 
interferon (113). As proliferation begins to slow the cells differentiate in Gl and 
lose most of these functions as they enter into GO' Resident macrophages are 
thought to be in GO, while TG-macrophages are found in late Gl (11 2,11 3,114). 
According to this model, resident macrophages must pass from GO into late Gl in 
order to become activated for tumoricidal or bactericidal functions 
(112,1 1 3, 1 1 4). Lymphokine (T-3, T-9 or Y-IFN) alone is not capable of pushing 
resident macrophages from GO to late Gl and therefore they do not display 
tumoricidal functions. Thioglycol1ate macrophages, already present in late Gl , 
are induced to kill tumors with the addition of LK. 
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It has been shown that the number of transferrin receptors in TG­
macrophages is higher than in resident macro phages. After treatment with y­
IFN the number of transferrin receptors is markedly reduced; however, in 
resident macrophages levels remain unaffected (1 31). We obtained similar 
results in TG-macrophages, and in resident macrophages we saw only a slight 
decrease in transferrin binding after exposure to y-IFN. These findings indicate 
that resident macrophages are unresponsive to y -IFN because they lack or 
express very few receptors for this molecule. The failure of Y-IFN to alter the 
cytopathic effect of crude Naegleria lysates on resident macrophages is in line 
with this theory. Both T-3 and T-9 supernatants induce unique transferrin 
binding patterns in resident and TG-macrophage, distinct from y-IFN and appear 
to act differentially on these macrophage populations. Supernatant from T-9 
increased transferrin binding in both resident and TG-macrophage populations, 
while T-3 increased binding in resident cells only and had no effect on TG­
macrophages. 
The protective mechanism induced by T-3 or T-9 in resident macrophage 
populations could not be demonstrated in TG-macrophages using either LK. We 
speculate that macrophage in GO express receptors for the LK present in T-3 and 
T-9 supernatants. As these resting cells receive signals moving them 
sequentially from early to late Gl they begin to express receptors for y-IFN and 
lose receptors for T-3 and T-9 supernatants. 
W e  have shown that TG-macrophages can effectively destroy tumor cells 
after L K  treatment (T-3, T-9, or y-IFN). The addition of LPS was not necessary 
as a second signal but we can not rule out the possibility of low levels of 
endotoxin in the culture media. These macrophages were unable to demonstrate 
any lytiC effect or protection against Naegleria fowleri. Resident macrophages, 
which are thought to be functionally down-regulated and unresponsive to LK 
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signals (37,1 12,131) did not demonstrate any tumoricidal activities. However, 
treatment with T-3 or T-9 was able to protect resident cells from Naegleria 
lysates and induce amoebicidal activity, de"J0nstrating a capacity to respond to 
LK. This finding therefore demonstrates that resident macrophages may play a 
role in effector functions. 
The data in this paper supports earlier findings that lymphokines from 
different T-cell clones can activate distinct macrophage functions (3 1). T-3 and 
T-9 supernatants were shown to differ both serologically and biologically. The 
molecular moiety in T-3 and T-9 supernatants responsible for the induction of 
cytostatic activity is heat labile and sensitive to a-chymotrypsin and therefore 
is not endotoxin, but more likely a protein or glycoprotein. Furthermore, T-9 LK 
appears to have a molecular weight approximately that of y-IFN. 
It has been argued that MAF and y-IFN are one and the same 
(23,55, 89,106); however, there have been previously reported findings of cloned 
hybridoma cell lines exhibiting MAF activity and no y-IFN activity (31). While it 
is apparent that )'-IFN induces many of the functional characteristics of 
activation in macrophages, we offer supporting evidence that it is not the only 
form of macrophage activating factor. While both T-3 and T-9 supernatants 
induce some macrophage functions associated with y-IFN (89,138) they also 
contain activities not described to Y-IFN. Anti-Y-interferon is able to block 
tumor cell cytostasis induced by T-9 supernatants but not by T-3 supernatants. 
It can be concluded that this activity may be shared by both Y-IFN and a non-y­
IF N  LK. This non-Y-IFN molecule is responsible for protection against the 
cytopathic effects of Naegleria lysate. 
Our data supports the fact that distinct T cell subsets produce different 
lymphokines under various physiological conditions and that the effect these 
lymphokines have on macrophages depends upon the biochemical nature of the 
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responding macrophage population. We have introduced evidence that the signals 
for activation of macrophage populations in response to the protozoan, Naegleria 
fowleri and the bacterium, Bordetella pertussis are distinct from activation for 
tumoricidal activity, and appear to be more closely associated with the 
activation of bacteriocidal and anti-parasitic mechanisms which are not Y-IFN 
induced. Furthermore, we have proposed an association between the cell cycle 
and the responsiveness to specific LK. 
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